Results 61 to 70 of about 19,505 (226)

An Interesting Cause of Hyperandrogenemic Hirsutism

Case Reports in Endocrinology, 2014
Mild clinical signs of hyperandrogenism such as hirsutism may appear during the menopausal transition as part of the normal aging process, but the development of frank virilization suggests a specific source of androgen excess.
Murat Atmaca, İsmet Seven, Rıfkı Üçler, Murat Alay, Veysi Barut, Yaren Dirik, Yasin Sezgin   +6 more
doaj   +1 more source

Diagnostic Discordance in Recurrent Pregnancy Loss: Hysteroscopy Resolves Ultrasound–MRI Disagreement in Septate Uterus, but Concurrent Ovulation Induction Precludes Causal Attribution of the Reproductive Outcome

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Congenital uterine anomalies are an important and potentially treatable contributor to recurrent pregnancy loss (RPL). The septate uterus is the commonest Müllerian anomaly linked to first‐trimester loss, and its differentiation from the benign arcuate uterus is essential for management, yet imaging modalities may disagree.
Iftekhar Ahmed Sakib, Ayesa Perveen, Nishad Tasnim   +2 more
wiley   +1 more source

Markers of hyperandrogenism in South Asians with polycystic ovary syndrome

Sri Lanka Journal of Diabetes Endocrinology and Metabolism, 2014
Background: Many clinical and biochemical criteria are used to assess hyperandrogenism in subjects with polycystic ovary syndrome (PCOS). Standard indicators used to confirm hyperandrogenism are based predominantly on western data.
WMM Boteju, GDKN Karunarathna, SAD Udayangani, KGH Silva, CN Wijeyaratne   +4 more
doaj   +1 more source

Divergent effects of hyperandrogenemia on the female reproductive neuroendocrine axis under different physiological conditions

Journal of Neuroendocrinology, Volume 38, Issue 10, October 2026.
Abstract The hypothalamic–pituitary–gonadal (HPG) axis coordinates reproductive function and incorporates gonadal sex steroid feedback to regulate gonadotropin secretion in a homeostatic manner. In females, ovarian estrogens and progestins act as the primary negative feedback signals to suppress luteinizing hormone (LH) release, whereas in males ...
Lillian Rose, Alexander S. Kauffman
wiley   +1 more source

The effect of correction of serum level of vitamin D on hyperandrogenism in women with polycystic ovary syndrome and hypovitaminosis D

Clinical and Experimental Obstetrics & Gynecology, 2020
Background: Polycystic ovary syndrome (PCOS) is a common condition among female of reproductive age. Vitamin D may involve in the pathogenesis of PCOS.
A. M. Maysara, A. T. Nassar, H. K. Jubran   +2 more
doaj   +1 more source

Rheumatologic Manifestations of Patients With Type B Insulin Resistance

Arthritis Care &Research, Volume 78, Issue 9, Page 1195-1200, September 2026.
Objective The objectives of this study were to identify laboratory and clinical features associated with type B insulin resistance (TBIR), a rare condition caused by autoantibodies that inhibit the insulin receptor, most frequently occurring in the setting of systemic lupus erythematosus (SLE), and to increase awareness of this rare, life‐threatening ...
S. Amara Ogbonnaya, Sandra G. Williams, Raphael A. Kirou, Marissa Lightbourne, Rebecca J. Brown   +4 more
wiley   +1 more source

Variations of Steroid Hormone Metabolites in Serum and Urine in Polycystic Ovary Syndrome after Nafarelin Stimulation: Evidence for an Altered Corticoid Excretion. [PDF]

, 1995
To evaluate the clinical relevance of testing pituitary-ovarian responses in patients suffering from polycystic ovary syndrome (PCOS) with the GnRH agonist nafarelin, a 1.2-mg dose of nafarelin was given intranasally to 19 women with PCOS and 15 healthy ...
Roger, Müller, Burkhardt, Höss, Cornelia, Burkhardt Moller, Jacob, Karl, Thomas Strowitzki, Michael M. Weber, Kimmig, Rainer, Weber, Michael M., Engelhardt, Dieter, Luppa, Peter, A. Lob, Peter Luppa, Dieter Engelhardt, Karl Jacob, Cornelia H, Rainer Kimmig, Strowitzki, Thomas, Lobo, Rogerio A.   +18 more
core   +1 more source

Dyslipidemia involvement in the development of polycystic ovary syndrome

Taiwanese Journal of Obstetrics & Gynecology, 2019
Polycystic ovary syndrome (PCOS) is widely accepted as the most common endocrine abnormality in women of childbearing age and may be accompanied by dyslipidemia, hyperandrogenism, hyperinsulinemia, oxidative stress and infertility.
Qi Liu, Yuan-jie Xie, Li-hua Qu, Meng-xia Zhang, Zhong-cheng Mo   +4 more
doaj   +1 more source

Elucidating the Molecular Mechanisms of Vitex negundo L. in Polycystic Ovary Syndrome via Metabolomics‐Driven Network Pharmacology

Biomedical Chromatography, Volume 40, Issue 9, September 2026.
ABSTRACT Polycystic ovary syndrome (PCOS) is a hormonal disorder marked by irregular menstrual cycles, elevated androgen levels, ovarian cysts, hirsutism, acne and other symptoms. While conventional medications such as Metformin and Spironolactone are commonly prescribed, they are often associated with undesirable side effects.
Nishmitha R. Poojary, Neeharika Narisepalli Venkatasai, Kannath U. Sanjay, Supraja M. Kodanch, Padmalatha S. Rai   +4 more
wiley   +1 more source

Hyperandrogenism. Cases of Combination of Different Variants of Hyperandrogenism in Adolescent Girls with the Peripheral Form of Hyperandrogenism

Pediatrician (St. Petersburg), 2015
Hyperandrogenism is a pathological process associated with an excessive effect of androgens in a female organism. In addition to the appearance changes hyperandrogenism (HA) can declare itself by some disorders of reproductive system functioning (anovulation, sterility, miscarriage).
Elena Magometovna Bogatyreva, Galiya Fettyakhovna Kutusheva, Irina Nikolaevna Gogotadze, Anastasia Dmitrievna Zernyuk   +3 more
openaire   +1 more source